Search

Cris Loiren Rodriguez

Supervisory Patent Examiner (ID: 13791, Phone: (571)272-4964 , Office: P/3732 )

Most Active Art Unit
3763
Art Unit(s)
3306, 3772, 1612, 3734, 3633, 2763, 3763, 3732, 3783
Total Applications
1175
Issued Applications
574
Pending Applications
326
Abandoned Applications
279

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5538714 [patent_doc_number] => 20090220519 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-03 [patent_title] => 'ANTI-IL-22RA ANTIBODIES AND BINDING PARTNERS AND METHODS OF USING IN INFLAMMATION' [patent_app_type] => utility [patent_app_number] => 12/423699 [patent_app_country] => US [patent_app_date] => 2009-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 82949 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20090220519.pdf [firstpage_image] =>[orig_patent_app_number] => 12423699 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/423699
Methods of treatment using anti-IL-22RA antibodies Apr 13, 2009 Issued
Array ( [id] => 5479567 [patent_doc_number] => 20090202524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'PAI-1 EXPRESSION AND ACTIVITY INHIBITORS FOR THE TREATMENT OF OCULAR DISORDERS' [patent_app_type] => utility [patent_app_number] => 12/421456 [patent_app_country] => US [patent_app_date] => 2009-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 5814 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202524.pdf [firstpage_image] =>[orig_patent_app_number] => 12421456 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/421456
PAI-1 EXPRESSION AND ACTIVITY INHIBITORS FOR THE TREATMENT OF OCULAR DISORDERS Apr 8, 2009 Abandoned
Array ( [id] => 5385772 [patent_doc_number] => 20090227017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'NUCLEIC ACIDS ENCODING RECEPTOR FOR IL-17 HOMOLOGOUS POLYPEPTIDES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/417097 [patent_app_country] => US [patent_app_date] => 2009-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 67815 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227017.pdf [firstpage_image] =>[orig_patent_app_number] => 12417097 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/417097
NUCLEIC ACIDS ENCODING RECEPTOR FOR IL-17 HOMOLOGOUS POLYPEPTIDES AND USES THEREOF Apr 1, 2009 Abandoned
Array ( [id] => 5379730 [patent_doc_number] => 20090191569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'Mammalian Cytokines; Related Reagents' [patent_app_type] => utility [patent_app_number] => 12/414267 [patent_app_country] => US [patent_app_date] => 2009-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 21249 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191569.pdf [firstpage_image] =>[orig_patent_app_number] => 12414267 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/414267
IL-D80 polypeptides and IL-27 Mar 29, 2009 Issued
Array ( [id] => 5385771 [patent_doc_number] => 20090227016 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'IL-17 HOMOLOGOUS POLYPEPTIDES AND THERAPEUTIC USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/412796 [patent_app_country] => US [patent_app_date] => 2009-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 55 [patent_figures_cnt] => 55 [patent_no_of_words] => 75660 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227016.pdf [firstpage_image] =>[orig_patent_app_number] => 12412796 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/412796
Nucleic acids encoding receptor for IL-17 homologous polypeptides and therapeutic uses thereof Mar 26, 2009 Issued
Array ( [id] => 7499488 [patent_doc_number] => 20110262457 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'MODULATION OF THE IMMUNE RESPONSE' [patent_app_type] => utility [patent_app_number] => 12/933800 [patent_app_country] => US [patent_app_date] => 2009-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 13400 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0262/20110262457.pdf [firstpage_image] =>[orig_patent_app_number] => 12933800 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/933800
MODULATION OF THE IMMUNE RESPONSE Mar 18, 2009 Abandoned
Array ( [id] => 6071220 [patent_doc_number] => 20110046071 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-02-24 [patent_title] => 'GLP-1 Receptor Agonists And Related Active Pharmaceutical Ingredients For Treatment Of Cancer' [patent_app_type] => utility [patent_app_number] => 12/918512 [patent_app_country] => US [patent_app_date] => 2009-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 13435 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0046/20110046071.pdf [firstpage_image] =>[orig_patent_app_number] => 12918512 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/918512
GLP-1 Receptor Agonists And Related Active Pharmaceutical Ingredients For Treatment Of Cancer Mar 3, 2009 Abandoned
Array ( [id] => 7530443 [patent_doc_number] => 07842665 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-11-30 [patent_title] => 'IL-17A and IL-17F antagonists' [patent_app_type] => utility [patent_app_number] => 12/370309 [patent_app_country] => US [patent_app_date] => 2009-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 70505 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/842/07842665.pdf [firstpage_image] =>[orig_patent_app_number] => 12370309 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/370309
IL-17A and IL-17F antagonists Feb 11, 2009 Issued
Array ( [id] => 4543280 [patent_doc_number] => 07959908 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-14 [patent_title] => 'Methods of treating viral infections using IL-21' [patent_app_type] => utility [patent_app_number] => 12/355650 [patent_app_country] => US [patent_app_date] => 2009-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29283 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/959/07959908.pdf [firstpage_image] =>[orig_patent_app_number] => 12355650 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/355650
Methods of treating viral infections using IL-21 Jan 15, 2009 Issued
Array ( [id] => 5379311 [patent_doc_number] => 20090191150 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'METHODS OF TREATING INFECTIONS USING IL-21' [patent_app_type] => utility [patent_app_number] => 12/352153 [patent_app_country] => US [patent_app_date] => 2009-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29277 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191150.pdf [firstpage_image] =>[orig_patent_app_number] => 12352153 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/352153
METHODS OF TREATING INFECTIONS USING IL-21 Jan 11, 2009 Abandoned
Array ( [id] => 5392212 [patent_doc_number] => 20090209525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-20 [patent_title] => 'ENABLING METHODS TO IDENTIFY ALLOSTERIC MODULATORS OF RECEPTOR ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/340393 [patent_app_country] => US [patent_app_date] => 2008-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 19725 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20090209525.pdf [firstpage_image] =>[orig_patent_app_number] => 12340393 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/340393
ENABLING METHODS TO IDENTIFY ALLOSTERIC MODULATORS OF RECEPTOR ACTIVITY Dec 18, 2008 Abandoned
Array ( [id] => 5379375 [patent_doc_number] => 20090191214 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-30 [patent_title] => 'ANTI-HUMAN IL-21 MONOCLONAL ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/330334 [patent_app_country] => US [patent_app_date] => 2008-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 38516 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20090191214.pdf [firstpage_image] =>[orig_patent_app_number] => 12330334 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/330334
Anti-human IL-21 monoclonal antibodies Dec 7, 2008 Issued
Array ( [id] => 6025847 [patent_doc_number] => 20110053865 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'AMINO ACID SEQUENCES DIRECTED AGAINST HETERODIMERIC CYTOKINES AND/OR THEIR RECEPTORS AND POLYPEPTIDES COMPRISING THE SAME' [patent_app_type] => utility [patent_app_number] => 12/745052 [patent_app_country] => US [patent_app_date] => 2008-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 133 [patent_figures_cnt] => 133 [patent_no_of_words] => 161006 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20110053865.pdf [firstpage_image] =>[orig_patent_app_number] => 12745052 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/745052
AMINO ACID SEQUENCES DIRECTED AGAINST HETERODIMERIC CYTOKINES AND/OR THEIR RECEPTORS AND POLYPEPTIDES COMPRISING THE SAME Nov 26, 2008 Abandoned
Array ( [id] => 5479518 [patent_doc_number] => 20090202475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-13 [patent_title] => 'Compositions and methods for treatment of microbial disorders' [patent_app_type] => utility [patent_app_number] => 12/291380 [patent_app_country] => US [patent_app_date] => 2008-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 43607 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20090202475.pdf [firstpage_image] =>[orig_patent_app_number] => 12291380 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/291380
Compositions and methods for treatment of microbial disorders Nov 6, 2008 Abandoned
Array ( [id] => 5564106 [patent_doc_number] => 20090136959 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-28 [patent_title] => 'Novel genes encoding proteins having prognostic, diagnostic preventive, therapeutic, and other uses' [patent_app_type] => utility [patent_app_number] => 12/288775 [patent_app_country] => US [patent_app_date] => 2008-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 68 [patent_no_of_words] => 44544 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0136/20090136959.pdf [firstpage_image] =>[orig_patent_app_number] => 12288775 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/288775
Novel genes encoding proteins having prognostic, diagnostic preventive, therapeutic, and other uses Oct 22, 2008 Abandoned
Array ( [id] => 5935911 [patent_doc_number] => 20110212076 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-01 [patent_title] => 'Viral Therapeutic' [patent_app_type] => utility [patent_app_number] => 12/682978 [patent_app_country] => US [patent_app_date] => 2008-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20217 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20110212076.pdf [firstpage_image] =>[orig_patent_app_number] => 12682978 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/682978
Viral Therapeutic Oct 14, 2008 Abandoned
Array ( [id] => 6353271 [patent_doc_number] => 20100086548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'Use of Anti-IL-20 Antibody for Treating Rheumatoid Arthritis and Osteoporosis' [patent_app_type] => utility [patent_app_number] => 12/246715 [patent_app_country] => US [patent_app_date] => 2008-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4482 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20100086548.pdf [firstpage_image] =>[orig_patent_app_number] => 12246715 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/246715
Use of anti-IL-20 antibody for treating osteoporosis Oct 6, 2008 Issued
Array ( [id] => 6353272 [patent_doc_number] => 20100086549 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-08 [patent_title] => 'Use of Anti-IL-20 Antibody for Treating Stroke' [patent_app_type] => utility [patent_app_number] => 12/246691 [patent_app_country] => US [patent_app_date] => 2008-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3749 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20100086549.pdf [firstpage_image] =>[orig_patent_app_number] => 12246691 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/246691
Use of anti-IL-20 antibody for treating stroke Oct 6, 2008 Issued
Array ( [id] => 8063107 [patent_doc_number] => 20110245473 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-06 [patent_title] => 'Anti-IL-6 Receptor Antibody' [patent_app_type] => utility [patent_app_number] => 12/680112 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 60078 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0245/20110245473.pdf [firstpage_image] =>[orig_patent_app_number] => 12680112 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/680112
Anti-IL-6 Receptor Antibody Sep 25, 2008 Abandoned
Array ( [id] => 5447206 [patent_doc_number] => 20090048432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-19 [patent_title] => 'ANTI-IL-20 ANTIBODY AND ITS USE IN TREATING IL-20 ASSOCIATED INFLAMMATORY DISEASES' [patent_app_type] => utility [patent_app_number] => 12/238760 [patent_app_country] => US [patent_app_date] => 2008-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7224 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20090048432.pdf [firstpage_image] =>[orig_patent_app_number] => 12238760 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/238760
Anti-IL-20 antibody and its use in treating IL-20 associated inflammatory diseases Sep 25, 2008 Issued
Menu